Nutrien Agrees to Divest 50% Stake in Profertil for $600 Million

Nutrien Ltd. has agreed to divest its 50% equity interest in Argentine nitrogen producer Profertil S.A. for approximately $600 million to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda. This strategic move, anticipated to close by late 2025 and subject to a 90-day right of first refusal for the other equity holder, is intended to enable Nutrien to sharpen its focus on core competencies. Proceeds from the sale will be allocated towards growth investments, share repurchases, and debt reduction, aiming to enhance the company's overall earnings quality and cash flow.

Analysis

Nutrien Ltd. is executing a strategic portfolio simplification by divesting its 50% stake in the Argentine nitrogen producer, Profertil S.A., for approximately $600 million. This transaction values the asset at a multiple of roughly 10x its trailing four-quarter earnings contribution of $60 million, unlocking significant capital. The proceeds are earmarked for a disciplined capital allocation strategy, including funding growth investments, executing share repurchases, and reducing debt, which management asserts will enhance the quality of earnings and cash flow. This move aligns with Nutrien's goal of concentrating on core competencies and geographies. While the company's stock has already outperformed its industry over the past year with a 32.3% gain, this divestiture, expected to close by the end of 2025, signals a continued focus on optimizing its asset base for improved shareholder returns. The deal remains subject to a 90-day right of first refusal by the other equity holder, representing a minor contingency.

Key Decisions for Investors

• Investors should view this divestiture as a positive strategic step that simplifies Nutrien's portfolio and unlocks capital, reinforcing the investment thesis for those focused on operational efficiency and shareholder returns.
• Monitor management’s deployment of the $600 million in proceeds, as the effectiveness of their growth investments, share buybacks, and debt repayment will be critical in replacing the divested earnings and driving future stock performance.
• Consider the valuation impact of removing approximately $60 million in annual earnings from models, while recognizing the 10x P/E sale multiple as a favorable data point for valuing Nutrien's other non-core assets.